Viewing Study NCT04960202


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2025-12-26 @ 2:42 AM
Study NCT ID: NCT04960202
Status: COMPLETED
Last Update Posted: 2025-07-10
First Post: 2021-07-10
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-07-16
Start Date Type: ACTUAL
Primary Completion Date: 2021-12-09
Primary Completion Date Type: ACTUAL
Completion Date: 2022-04-25
Completion Date Type: ACTUAL
First Submit Date: 2021-07-10
First Submit QC Date: None
Study First Post Date: 2021-07-13
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-11-22
Results First Submit QC Date: None
Results First Post Date: 2023-02-09
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-08
Last Update Post Date: 2025-07-10
Last Update Post Date Type: ACTUAL